Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
125
datasets available to search
ShareScore release 0.9.0
Dataset results
125 results for “Relapsing-remitting multiple sclerosis”
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
ClinicalTrials.gov study NCT01111656. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT02776072. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT03000647. IPD Sharing: NO. Countries: 1. Publications: 6.
A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02038049. IPD Sharing: YES. Countries: 3. Publications: 0.
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00206635. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02308670. IPD Sharing: NO. Countries: 1. Publications: 1.
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04380220. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
ClinicalTrials.gov study NCT00937677. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients
ClinicalTrials.gov study NCT01201343. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants
ClinicalTrials.gov study NCT01485003. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07235644. IPD Sharing: YES. Countries: 1. Publications: 10.
An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing T
ClinicalTrials.gov study NCT01112345. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00492765. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients
ClinicalTrials.gov study NCT02939079. IPD Sharing: UNDECIDED. Countries: 0. Publications: 7.
Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
ClinicalTrials.gov study NCT00942591. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT00213135. IPD Sharing: Not stated. Countries: 0. Publications: 14.
Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00662649. IPD Sharing: Not stated. Countries: 22. Publications: 0.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01433250. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00235989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT02687919. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.